Clinical trial · Observational
Functional Outcomes Following Hip Core Decompression in Younger Participants With Osteonecrosis
Functional Outcomes for Children, Adolescents, and Young Adults With Osteonecrosis Following Hip Core Decompression
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Although uncommon in the general pediatric population, osteonecrosis (ON) is prevalent in children and adolescents with cancer, particularly among those that have had chronic exposure to glucocorticoids and among those having undergone allogeneic hematopoietic stem cell transplantation. Patients with hematologic disease are also at risk for developing ON. Hip Core Decompression (HCD) is a widely used surgical procedure with several studies reporting positive results; however, most are subject to criticism because of the limited sample size or the absence of appropriate functional outcome measures. The objective of this pilot study is to observe and collect information on several functional outcome measures and assess if Hip Core Decompression (HCD) potentially improves functional outcomes in children, adolescents and young adults with osteonecrosis. PRIMARY OBJECTIVE: * To describe functional outcomes of children, adolescents, and young adults with osteonecrosis of the femoral head following hip core decompression surgery. Parameters assessed will include pain, functional mobility, endurance, quality of life, and gait patterns pre-operatively and post-operatively over time.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Osteonecrosis | — | UNRESOLVED | — |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Functional Mobility Assessment | Other | — | UNRESOLVED |
| GAITRite® System | Other | — | UNRESOLVED |
| Range of Motion | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Osteonecrosis
- description
- Observational measures of functional outcomes will be obtained from all participants who consent to and complete the study. Interventions: Functional Mobility Assessment (FMA), GAITRite® System, and Range of Motion.
- interventionNames
- Other: Functional Mobility Assessment
- Other: GAITRite® System
- Other: Range of Motion
Primary outcomes (6)
- measure
- Degree of Pain
- timeFrame
- At 1 year after surgery
- description
- Pain is measured by using a numeric scale requiring patients to rate any pain experienced in the prior week on a 0 (no pain) to 10 (worst pain imaginable) scale
- measure
- Functional Mobility
- timeFrame
- At 1 year after surgery
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 8 Years
- Maximum age
- 29 Years
Show eligibility criteria text
Inclusion Criteria: * Patient being treated at St. Jude Children's Research Hospital * Diagnosis of osteonecrosis of the hip * Diagnosis of hematologic malignancy or sickle cell disease * Age between 8 and 29 years of age * Patient and/or parent or legal guardian must sign a written informed consent * Patient is considered an acceptable candidate for hip core decompression surgery by his/her primary physician and orthopedic surgeon Exclusion Criteria: * Patient with a diagnosis that is not a hematologic malignancy or sickle cell disease * Patient that has had amputation or reconstructive surgery of the lower extremities * Premorbid condition that prevents patient from ambulating * Patient that has a serious, non-healing wound, ulcer, or bone fracture
References
Publications (0)
Data not yet available